Glucotrack Seeks Stockholder Approval for Reverse Split and Full Issuance of Shares Under September Financing and PIPE Warrant
GCTK is trading near its 52-week low of $1 (5.0% above the low).
Summary
Glucotrack seeks stockholder approval for a reverse stock split and full issuance of shares under its September Financing and PIPE Warrant, which could exceed 20% of outstanding shares and cause significant dilution.
Key Events · Corporate Governance and Compliance · GCTK
-
Reverse Stock Split Proposal
Proposal 3 seeks approval for one or more reverse stock splits at an aggregate ratio not to exceed 1-for-[ ], to maintain Nasdaq listing compliance. Current outstanding shares are 2,368,237; a 1:2 split would reduce to 1,184,119 shares.
-
September Financing Share Issuance
Proposal 1 seeks approval for full issuance of shares upon conversion of $11.6M September Notes (22% OID, 8% interest, 9-month maturity) and exercise of 4,831,739 September Warrants at $7.50 per share. Conversion price is lower of $3.12 or 80% of 15-day VWAP, with a floor price of 20% of Nasdaq Minimum Price.
-
PIPE Warrant Share Issuance
Proposal 2 seeks approval for full issuance of 2,666,667 shares upon exercise of the PIPE Warrant at $1.50 per share, issued August 4, 2026. The warrant has a 5-year term and 9.99% beneficial ownership limitation.
-
Amendments Remove Floor Price Adjustments
September Note Amendment and September Warrant Amendment (effective September 28, 2026) removed provisions permitting downward adjustment to the Floor Price, making it an absolute floor. PIPE Warrant Amendment No. 2 (September 22, 2026) similarly removed downward Floor Price adjustments.
Analysis · GCTK · Industrial Applications And Services
Glucotrack is asking stockholders to approve a reverse stock split and the full issuance of shares underlying its September Financing and PIPE Warrant. The September Financing raised $4.5M in cash via $11.6M of convertible notes with a 22% OID and variable-price conversion, plus warrants to purchase 4,831,739 shares. The PIPE Warrant covers 2,666,667 shares at $1.50 per share. If approved, these issuances could exceed 20% of outstanding shares, causing significant dilution. The reverse split is needed to maintain Nasdaq listing compliance, as the stock trades near its 52-week low of $1.00. The filing also discloses new amendments removing downward Floor Price adjustments, which limits further dilution but also removes a potential downside protection for investors. The company faces going concern doubt and a cash crisis, making these approvals critical for survival.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 47.7% of the 235 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GCTK was trading at $1.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1M. The 52-week trading range was $1.00 to $112.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.